跳至主要内容
临床试验/NL-OMON27917
NL-OMON27917招募中不适用

Early effects of Vaccine Immunisation (EVI) study

Dutch Ministry of Health, welfare and Sports0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ? Seronegative for hr-HPV vaccine types(16,18,31,33,45,52,58)
  • ? Normal general health
  • ? Pre-menopausal
  • ? Willing to receive HPV vaccination
  • ? Provision of written informed consent
  • ? Willing to adhere to the protocol and be available during the study period

排除标准

  • present evidence of serious disease(s) within the last 3 months before inclusion
  • requiring immunosuppressive or immune modulating medical treatment, such as
  • systemic corticosteroids, that might interfere with the results of the study;
  • ? chronic infection
  • ? known or suspected immune deficiency;
  • ? history of any neurologic disorder, including epilepsy;
  • ? previous administration of serum products (including immunoglobulins) within 6
  • months before vaccination and blood sampling
  • ? known or suspected allergy to any of the vaccine components (by medical history)
  • ? previous vaccination with any HPV vaccine
  • ? pregnancy
  • ? participating in another vaccination/ medicine study

研究者

发起方
Dutch Ministry of Health, welfare and Sports

相似试验